MedImmune Ventures, Inc.
Insider CIK 1291884 · AGTC 10% owner · ITEK 10% owner · CATB 10% owner · GTHX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GTHX G1 Therapeutics, Inc. | S Sale | 2017-12-15 | 2017-12-18 | 200,000 | $19.75 | $3.95M | 2,950,630 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2017-12-01 | 2017-12-05 | 133,906 | $19.75 | $2.64M | 3,150,630 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2017-11-20 | 2017-11-22 | 200,000 | $20.01 | $4.00M | 3,284,536 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 7,142,857 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 2,412,628 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 673,128 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | P Buy | 2017-05-22 | 2017-05-24 | 75,000 | $15.00 | $1.13M | 3,484,536 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion | 2017-05-22 | 2017-05-24 | 3,409,536 | — | $0 | 3,409,536 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | P Buy | 2017-05-17 | 2017-12-13 | 75,000 | $15.00 | $1.13M | 3,409,536 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 4,241,780 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 13,866,666 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 330,098 | — | $0 | 1,409,213 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | P Buy | 2015-06-30 | 2015-06-30 | 223,439 | $12.00 | $2.68M | 1,632,652 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 1,079,115 | — | $0 | 1,079,115 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion deriv | 2015-02-23 | 2015-02-25 | 338,551 | — | $0 | 0 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion deriv | 2015-02-23 | 2015-02-25 | 4,013,692 | — | $0 | 0 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion | 2015-02-23 | 2015-02-25 | 1,255,123 | — | $0 | 1,444,035 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | P Buy | 2015-02-23 | 2015-02-25 | 416,667 | $6.00 | $2.50M | 1,917,906 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion | 2015-02-23 | 2015-02-25 | 57,204 | — | $0 | 1,501,239 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 11,478,652 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 6,409,436 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 5,699,111 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 416,361 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 11,896 | — | $0 | 11,896 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 11,893,926 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | P Buy | 2014-04-01 | 2014-04-01 | 75,735 | $12.00 | $908.8K | 1,452,196 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion | 2014-04-01 | 2014-04-01 | 1,376,461 | — | $0 | 1,376,461 | SEC↗ |